United States Intravenous Immunoglobulin (IVIg) Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Intravenous Immunoglobulin (IVIg) Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Intravenous Immunoglobulin (IVIg) Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Intravenous Immunoglobulin (IVIg) Overall Market Size
2.1 United States Intravenous Immunoglobulin (IVIg) Market Size: 2021 VS 2027
2.2 United States Intravenous Immunoglobulin (IVIg) Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Intravenous Immunoglobulin (IVIg) Sales: 2016-2027
3 Company Landscape
3.1 Top Intravenous Immunoglobulin (IVIg) Players in United States Market
3.2 Top United States Intravenous Immunoglobulin (IVIg) Companies Ranked by Revenue
3.3 United States Intravenous Immunoglobulin (IVIg) Revenue by Companies
3.4 United States Intravenous Immunoglobulin (IVIg) Sales by Companies
3.5 United States Intravenous Immunoglobulin (IVIg) Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Intravenous Immunoglobulin (IVIg) Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Intravenous Immunoglobulin (IVIg) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Intravenous Immunoglobulin (IVIg) Players in United States Market
3.8.1 List of Tier 1 Intravenous Immunoglobulin (IVIg) Companies in United States
3.8.2 List of Tier 2 and Tier 3 Intravenous Immunoglobulin (IVIg) Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Intravenous Immunoglobulin (IVIg) Market Size Markets, 2021 & 2027
4.1.2 IVIg Liquid
4.1.3 IVIg Powder
4.2 By Type - United States Intravenous Immunoglobulin (IVIg) Revenue & Forecasts
4.2.1 By Type - United States Intravenous Immunoglobulin (IVIg) Revenue, 2016-2021
4.2.2 By Type - United States Intravenous Immunoglobulin (IVIg) Revenue, 2022-2027
4.2.3 By Type - United States Intravenous Immunoglobulin (IVIg) Revenue Market Share, 2016-2027
4.3 By Type - United States Intravenous Immunoglobulin (IVIg) Sales & Forecasts
4.3.1 By Type - United States Intravenous Immunoglobulin (IVIg) Sales, 2016-2021
4.3.2 By Type - United States Intravenous Immunoglobulin (IVIg) Sales, 2022-2027
4.3.3 By Type - United States Intravenous Immunoglobulin (IVIg) Sales Market Share, 2016-2027
4.4 By Type - United States Intravenous Immunoglobulin (IVIg) Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Intravenous Immunoglobulin (IVIg) Market Size, 2021 & 2027
5.1.2 Immunodeficiency
5.1.3 Autoimmune Disease
5.1.4 Acute Infection
5.2 By Application - United States Intravenous Immunoglobulin (IVIg) Revenue & Forecasts
5.2.1 By Application - United States Intravenous Immunoglobulin (IVIg) Revenue, 2016-2021
5.2.2 By Application - United States Intravenous Immunoglobulin (IVIg) Revenue, 2022-2027
5.2.3 By Application - United States Intravenous Immunoglobulin (IVIg) Revenue Market Share, 2016-2027
5.3 By Application - United States Intravenous Immunoglobulin (IVIg) Sales & Forecasts
5.3.1 By Application - United States Intravenous Immunoglobulin (IVIg) Sales, 2016-2021
5.3.2 By Application - United States Intravenous Immunoglobulin (IVIg) Sales, 2022-2027
5.3.3 By Application - United States Intravenous Immunoglobulin (IVIg) Sales Market Share, 2016-2027
5.4 By Application - United States Intravenous Immunoglobulin (IVIg) Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Baxter
6.1.1 Baxter Corporation Information
6.1.2 Baxter Overview
6.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales and Revenue in United States Market (2016-2021)
6.1.4 Baxter Intravenous Immunoglobulin (IVIg) Product Description
6.1.5 Baxter Recent Developments
6.2 Grifols
6.2.1 Grifols Corporation Information
6.2.2 Grifols Overview
6.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales and Revenue in United States Market (2016-2021)
6.2.4 Grifols Intravenous Immunoglobulin (IVIg) Product Description
6.2.5 Grifols Recent Developments
6.3 CSL
6.3.1 CSL Corporation Information
6.3.2 CSL Overview
6.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales and Revenue in United States Market (2016-2021)
6.3.4 CSL Intravenous Immunoglobulin (IVIg) Product Description
6.3.5 CSL Recent Developments
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Overview
6.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales and Revenue in United States Market (2016-2021)
6.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Product Description
6.4.5 Octapharma Recent Developments
6.5 Biotest
6.5.1 Biotest Corporation Information
6.5.2 Biotest Overview
6.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales and Revenue in United States Market (2016-2021)
6.5.4 Biotest Intravenous Immunoglobulin (IVIg) Product Description
6.5.5 Biotest Recent Developments
6.6 Kedrion
6.6.1 Kedrion Corporation Information
6.6.2 Kedrion Overview
6.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales and Revenue in United States Market (2016-2021)
6.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Product Description
6.6.5 Kedrion Recent Developments
6.7 Hualan Bio
6.7.1 Hualan Bio Corporation Information
6.7.2 Hualan Bio Overview
6.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales and Revenue in United States Market (2016-2021)
6.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Description
6.7.5 Hualan Bio Recent Developments
6.8 CNBG
6.8.1 CNBG Corporation Information
6.8.2 CNBG Overview
6.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales and Revenue in United States Market (2016-2021)
6.8.4 CNBG Intravenous Immunoglobulin (IVIg) Product Description
6.8.5 CNBG Recent Developments
6.9 Shanghai RAAS
6.9.1 Shanghai RAAS Corporation Information
6.9.2 Shanghai RAAS Overview
6.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales and Revenue in United States Market (2016-2021)
6.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Description
6.9.5 Shanghai RAAS Recent Developments
6.10 CBPO
6.10.1 CBPO Corporation Information
6.10.2 CBPO Overview
6.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales and Revenue in United States Market (2016-2021)
6.10.4 CBPO Intravenous Immunoglobulin (IVIg) Product Description
6.10.5 CBPO Recent Developments
6.11 LFB Group
6.11.1 LFB Group Corporation Information
6.11.2 LFB Group Overview
6.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales and Revenue in United States Market (2016-2021)
6.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Product Description
6.11.5 LFB Group Recent Developments
6.12 BPL
6.12.1 BPL Corporation Information
6.12.2 BPL Overview
6.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales and Revenue in United States Market (2016-2021)
6.12.4 BPL Intravenous Immunoglobulin (IVIg) Product Description
6.12.5 BPL Recent Developments
6.13 Sichuan Yuanda Shuyang
6.13.1 Sichuan Yuanda Shuyang Corporation Information
6.13.2 Sichuan Yuanda Shuyang Overview
6.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales and Revenue in United States Market (2016-2021)
6.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Description
6.13.5 Sichuan Yuanda Shuyang Recent Developments
7 United States Intravenous Immunoglobulin (IVIg) Production Capacity, Analysis
7.1 United States Intravenous Immunoglobulin (IVIg) Production Capacity, 2016-2027
7.2 Intravenous Immunoglobulin (IVIg) Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Intravenous Immunoglobulin (IVIg) Supply Chain Analysis
9.1 Intravenous Immunoglobulin (IVIg) Industry Value Chain
9.2 Intravenous Immunoglobulin (IVIg) Upstream Market
9.3 Intravenous Immunoglobulin (IVIg) Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Intravenous Immunoglobulin (IVIg) Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Intravenous Immunoglobulin (IVIg) in United States Market
Table 2. Top Intravenous Immunoglobulin (IVIg) Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Intravenous Immunoglobulin (IVIg) Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Intravenous Immunoglobulin (IVIg) Revenue Share by Companies, 2016-2021
Table 5. United States Intravenous Immunoglobulin (IVIg) Sales by Companies, (K Bottle), 2016-2021
Table 6. United States Intravenous Immunoglobulin (IVIg) Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Intravenous Immunoglobulin (IVIg) Price (2016-2021) & (USD/Bottle)
Table 8. Manufacturers Intravenous Immunoglobulin (IVIg) Product Type
Table 9. List of Tier 1 Intravenous Immunoglobulin (IVIg) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Intravenous Immunoglobulin (IVIg) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of IVIg Liquid
Table 12. Major Manufacturers of IVIg Powder
Table 13. By Type - United States Intravenous Immunoglobulin (IVIg) Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Intravenous Immunoglobulin (IVIg) Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Intravenous Immunoglobulin (IVIg) Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Intravenous Immunoglobulin (IVIg) Sales (K Bottle), 2016-2021
Table 17. By Type - United States Intravenous Immunoglobulin (IVIg) Sales (K Bottle), 2022-2027
Table 18. By Application - United States Intravenous Immunoglobulin (IVIg) Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Intravenous Immunoglobulin (IVIg) Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Intravenous Immunoglobulin (IVIg) Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Intravenous Immunoglobulin (IVIg) Sales (K Bottle), 2016-2021
Table 22. By Application - United States Intravenous Immunoglobulin (IVIg) Sales (K Bottle), 2022-2027
Table 23. Baxter Corporation Information
Table 24. Baxter Description and Major Businesses
Table 25. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$, Mn) and Gross Margin (USD/Bottle) (2016-2021)
Table 26. Baxter Intravenous Immunoglobulin (IVIg) Product
Table 27. Baxter Recent Developments
Table 28. Grifols Corporation Information
Table 29. Grifols Description and Major Businesses
Table 30. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$, Mn) and Gross Margin (USD/Bottle) (2016-2021)
Table 31. Grifols Intravenous Immunoglobulin (IVIg) Product
Table 32. Grifols Recent Developments
Table 33. CSL Corporation Information
Table 34. CSL Description and Major Businesses
Table 35. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$, Mn) and Gross Margin (USD/Bottle) (2016-2021)
Table 36. CSL Intravenous Immunoglobulin (IVIg) Product
Table 37. CSL Recent Developments
Table 38. Octapharma Corporation Information
Table 39. Octapharma Description and Major Businesses
Table 40. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$, Mn) and Gross Margin (USD/Bottle) (2016-2021)
Table 41. Octapharma Intravenous Immunoglobulin (IVIg) Product
Table 42. Octapharma Recent Developments
Table 43. Biotest Corporation Information
Table 44. Biotest Description and Major Businesses
Table 45. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$, Mn) and Gross Margin (USD/Bottle) (2016-2021)
Table 46. Biotest Intravenous Immunoglobulin (IVIg) Product
Table 47. Biotest Recent Developments
Table 48. Kedrion Corporation Information
Table 49. Kedrion Description and Major Businesses
Table 50. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$, Mn) and Gross Margin (USD/Bottle) (2016-2021)
Table 51. Kedrion Intravenous Immunoglobulin (IVIg) Product
Table 52. Kedrion Recent Developments
Table 53. Hualan Bio Corporation Information
Table 54. Hualan Bio Description and Major Businesses
Table 55. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$, Mn) and Gross Margin (USD/Bottle) (2016-2021)
Table 56. Hualan Bio Intravenous Immunoglobulin (IVIg) Product
Table 57. Hualan Bio Recent Developments
Table 58. CNBG Corporation Information
Table 59. CNBG Description and Major Businesses
Table 60. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$, Mn) and Gross Margin (USD/Bottle) (2016-2021)
Table 61. CNBG Intravenous Immunoglobulin (IVIg) Product
Table 62. CNBG Recent Developments
Table 63. Shanghai RAAS Corporation Information
Table 64. Shanghai RAAS Description and Major Businesses
Table 65. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$, Mn) and Gross Margin (USD/Bottle) (2016-2021)
Table 66. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product
Table 67. Shanghai RAAS Recent Developments
Table 68. CBPO Corporation Information
Table 69. CBPO Description and Major Businesses
Table 70. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$, Mn) and Gross Margin (USD/Bottle) (2016-2021)
Table 71. CBPO Intravenous Immunoglobulin (IVIg) Product
Table 72. CBPO Recent Developments
Table 73. LFB Group Corporation Information
Table 74. LFB Group Description and Major Businesses
Table 75. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$, Mn) and Gross Margin (USD/Bottle) (2016-2021)
Table 76. LFB Group Intravenous Immunoglobulin (IVIg) Product
Table 77. LFB Group Recent Developments
Table 78. BPL Corporation Information
Table 79. BPL Description and Major Businesses
Table 80. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$, Mn) and Gross Margin (USD/Bottle) (2016-2021)
Table 81. BPL Intravenous Immunoglobulin (IVIg) Product
Table 82. BPL Recent Developments
Table 83. Sichuan Yuanda Shuyang Corporation Information
Table 84. Sichuan Yuanda Shuyang Description and Major Businesses
Table 85. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$, Mn) and Gross Margin (USD/Bottle) (2016-2021)
Table 86. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product
Table 87. Sichuan Yuanda Shuyang Recent Developments
Table 88. Intravenous Immunoglobulin (IVIg) Production Capacity (K Bottle) of Key Manufacturers in United States Market, 2019-2021 (K Bottle)
Table 89. United States Intravenous Immunoglobulin (IVIg) Capacity Market Share of Key Manufacturers, 2019-2021
Table 90. Intravenous Immunoglobulin (IVIg) Market Opportunities & Trends in United States Market
Table 91. Intravenous Immunoglobulin (IVIg) Market Drivers in United States Market
Table 92. Intravenous Immunoglobulin (IVIg) Market Restraints in United States Market
Table 93. Intravenous Immunoglobulin (IVIg) Raw Materials
Table 94. Intravenous Immunoglobulin (IVIg) Raw Materials Suppliers in United States Market
Table 95. Typical Intravenous Immunoglobulin (IVIg) Downstream
Table 96. Intravenous Immunoglobulin (IVIg) Downstream Clients in United States Market
Table 97. Intravenous Immunoglobulin (IVIg) Distributors and Sales Agents in United States Market
List of FiguresFigure 1. Intravenous Immunoglobulin (IVIg) Product Picture
Figure 2. Intravenous Immunoglobulin (IVIg) Segment by Type
Figure 3. Intravenous Immunoglobulin (IVIg) Segment by Application
Figure 4. United States Intravenous Immunoglobulin (IVIg) Market Overview: 2020
Figure 5. United States Intravenous Immunoglobulin (IVIg) Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Intravenous Immunoglobulin (IVIg) Revenue, 2016-2027 (US$, Mn)
Figure 7. Intravenous Immunoglobulin (IVIg) Sales in United States Market: 2016-2027 (K Bottle)
Figure 8. The Top 3 and 5 Players Market Share by Intravenous Immunoglobulin (IVIg) Revenue in 2020
Figure 9. IVIg Liquid Product Picture
Figure 10. IVIg Powder Product Picture
Figure 11. By Type - United States Intravenous Immunoglobulin (IVIg) Sales Market Share, 2016-2027
Figure 12. By Type - United States Intravenous Immunoglobulin (IVIg) Revenue Market Share, 2016-2027
Figure 13. By Type - United States Intravenous Immunoglobulin (IVIg) Price (USD/Bottle), 2016-2027
Figure 14. Immunodeficiency
Figure 15. Autoimmune Disease
Figure 16. Acute Infection
Figure 17. By Application - United States Intravenous Immunoglobulin (IVIg) Sales Market Share, 2016-2027
Figure 18. By Application - United States Intravenous Immunoglobulin (IVIg) Revenue Market Share, 2016-2027
Figure 19. By Application - United States Intravenous Immunoglobulin (IVIg) Price (USD/Bottle), 2016-2027
Figure 20. Baxter Intravenous Immunoglobulin (IVIg) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Grifols Intravenous Immunoglobulin (IVIg) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. CSL Intravenous Immunoglobulin (IVIg) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Octapharma Intravenous Immunoglobulin (IVIg) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Biotest Intravenous Immunoglobulin (IVIg) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Kedrion Intravenous Immunoglobulin (IVIg) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Hualan Bio Intravenous Immunoglobulin (IVIg) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. CNBG Intravenous Immunoglobulin (IVIg) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. CBPO Intravenous Immunoglobulin (IVIg) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. LFB Group Intravenous Immunoglobulin (IVIg) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. BPL Intravenous Immunoglobulin (IVIg) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. United States Intravenous Immunoglobulin (IVIg) Production Capacity (K Bottle), 2016-2027
Figure 34. Intravenous Immunoglobulin (IVIg) Industry Value Chain
Figure 35. Marketing Channels